NO20010044L - Use of texaphyrins in macrophage-mediated diseases - Google Patents

Use of texaphyrins in macrophage-mediated diseases

Info

Publication number
NO20010044L
NO20010044L NO20010044A NO20010044A NO20010044L NO 20010044 L NO20010044 L NO 20010044L NO 20010044 A NO20010044 A NO 20010044A NO 20010044 A NO20010044 A NO 20010044A NO 20010044 L NO20010044 L NO 20010044L
Authority
NO
Norway
Prior art keywords
texaphyrins
macrophage
mediated diseases
mediated
diseases
Prior art date
Application number
NO20010044A
Other languages
Norwegian (no)
Other versions
NO20010044D0 (en
Inventor
Kathryn W Woodburn
Stuart W Young
Original Assignee
Pharmacyclics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacyclics Inc filed Critical Pharmacyclics Inc
Publication of NO20010044D0 publication Critical patent/NO20010044D0/en
Publication of NO20010044L publication Critical patent/NO20010044L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0076—PDT with expanded (metallo)porphyrins, i.e. having more than 20 ring atoms, e.g. texaphyrins, sapphyrins, hexaphyrins, pentaphyrins, porphocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
NO20010044A 1998-07-06 2001-01-04 Use of texaphyrins in macrophage-mediated diseases NO20010044L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11050998A 1998-07-06 1998-07-06
PCT/US1999/015199 WO2000001414A1 (en) 1998-07-06 1999-07-06 Use of texaphyrins in macrophage-mediated disease

Publications (2)

Publication Number Publication Date
NO20010044D0 NO20010044D0 (en) 2001-01-04
NO20010044L true NO20010044L (en) 2001-03-01

Family

ID=22333401

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010044A NO20010044L (en) 1998-07-06 2001-01-04 Use of texaphyrins in macrophage-mediated diseases

Country Status (8)

Country Link
EP (1) EP1094840A1 (en)
JP (1) JP2002519390A (en)
KR (1) KR20010079498A (en)
AR (1) AR019226A1 (en)
AU (1) AU4860899A (en)
CA (1) CA2336134A1 (en)
NO (1) NO20010044L (en)
WO (1) WO2000001414A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6163988A (en) * 1995-05-17 2000-12-26 Rockland, Inc. Assembly connectable to an operating arm of a machine for performing work functions
RU2106146C1 (en) 1995-07-17 1998-03-10 Институт элементоорганических соединений РАН Means to inhibit tumor growth
US7579338B2 (en) 1999-10-29 2009-08-25 Pharmacyclics, Inc. Methods and compositions for treating atheroma, tumors and other neoplastic tissues
WO2001032210A2 (en) 1999-10-29 2001-05-10 Pharmacyclics, Inc. Compositions for treating atheroma and neoplastic tissue
JP2003012547A (en) * 2001-06-27 2003-01-15 Meiji Seika Kaisha Ltd Diagnostic and therapeutic agent for insulin dependent diabetes mellitus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5457183A (en) * 1989-03-06 1995-10-10 Board Of Regents, The University Of Texas System Hydroxylated texaphyrins
US5419760A (en) * 1993-01-08 1995-05-30 Pdt Systems, Inc. Medicament dispensing stent for prevention of restenosis of a blood vessel
US6008211A (en) * 1995-07-27 1999-12-28 Pdt Pharmaceuticals, Inc. Photoactivatable compounds comprising benzochlorin and furocoumarin
US5913884A (en) * 1996-09-19 1999-06-22 The General Hospital Corporation Inhibition of fibrosis by photodynamic therapy

Also Published As

Publication number Publication date
JP2002519390A (en) 2002-07-02
EP1094840A1 (en) 2001-05-02
NO20010044D0 (en) 2001-01-04
AU4860899A (en) 2000-01-24
AR019226A1 (en) 2001-12-26
WO2000001414A1 (en) 2000-01-13
CA2336134A1 (en) 2000-01-13
KR20010079498A (en) 2001-08-22

Similar Documents

Publication Publication Date Title
ID22565A (en) USE OF NANODISPERION IN FINAL DRUG FORMULATION
PT1028954E (en) IMIDAZOLES SUBSTITUIDOS UTEIS IN THE TREATMENT OF INFLAMMATORY DISEASES
EE200100480A (en) Xenon for use in the treatment of nerve poisoning
EE200100370A (en) Novel aralkylamines of spirofuropyridines used in therapy
DE69929047D1 (en) HAIR TREATMENT AGENT
AU7375100A (en) Water absorbent keratin and gel formed therefrom
ATE246485T1 (en) SKIN CLEANSER
DE69512841D1 (en) Skin disinfection formulation
DE60024988D1 (en) PREPARATION OF THERAPEUTIC MICROSCIENTS
DE69931855D1 (en) skin preparation
DE69524138D1 (en) Skin treatment agents
LV12624A (en) Thienylazolylalcoxyethanamines their preparation and their application as medicaments
IS5504A (en) Composition active in the treatment of impotence
ID18679A (en) USE OF FURTHER THERAPY
PT1017408E (en) USE OF TETRA-HYDROLYSTERATIN IN TREATMENT OF TYPE II DIABETES
ID27576A (en) USE OF CYCOSPORINE IN TREATMENT OF AUTOIMUN DISEASE DISEASES
DE69732024D1 (en) HAIR TREATMENT AGENT
PT932400E (en) DERIVATIVES OF USED ANTICONVULSIONERS IN THE TREATMENT OF NEUROPATIC PAIN
PT984777E (en) AILOSUBSTITUIDAL PILOTAZINES IN THE TREATMENT OF BENOSTINE PROSTATE HYPERPLASIA
ID23174A (en) OPEN DENTAL WHEEL INGREDIENTS
NO20010044L (en) Use of texaphyrins in macrophage-mediated diseases
DE59708501D1 (en) HAIR TREATMENT AGENT
ID30458A (en) OSANETAN IN TREATMENT OF SOUL DISORDERS
DE69901795T2 (en) COMPOSITION WITH LESS SKIN IRRITATION
DE29818627U1 (en) Therapy chair

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application